Persistent airway obstruction in asthma

American Journal of Respiratory and Critical Care Medicine

Volumn 187, Issue 1, 2013, Pages 1-2

  Peter, Lange ^a,b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b HVIDOVRE HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; CORTICOSTEROID; IMMUNOGLOBULIN E;

ASTHMA; ATOPY; BRONCHOSPIROGRAPHY; BRONCHUS HYPERREACTIVITY; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; DISEASE EXACERBATION; DISEASE SEVERITY; EDITORIAL; FOLLOW UP; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; LUNG DIFFUSION CAPACITY; LUNG FUNCTION; LUNG VOLUME; MEDICAL SOCIETY; PATHOGENESIS; PATHOPHYSIOLOGY; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PULMONARY FUNCTION PREDICTED VALUES CALCULATOR; RISK FACTOR; SKIN TEST; SMOKING;

AIRWAY OBSTRUCTION; ASTHMA; FEMALE; HUMANS; MALE; SMOKING;

EID: 84871989312     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201211-1966ED     Document Type: Editorial

References (15)

1. Brown PJ, Greville HG, Finucane KE. Asthma and reversible airflow obstruction. Thorax 1984;39:131-136.
2. Peat JK, Woolcock AJ, Cullen K. Rate of decline of lung function in subjects with asthma. Eur J Respir Dis 1987;70:171-179. (Pubitemid 17029522)
3. Ulrik CS. Outcome of asthma: longitudinal changes in lung function. Eur Respir J 1999;13:904-918. (Pubitemid 29234799)
4. Lange P, Parner J, Vestbo J, Jensen G, Schnohr P. A 15-yr follow-up of ventilatory function in adults with asthma. N Engl J Med 1998;339:1194-1200.
5. Panhuysen CIM, Vonk JM, Koeter GH, Schouten JC, van Altena R, Bleecker ER, Postma DS. Adult patients may outgrow their asthma: a 25-year follow-up study. Am J Respir Crit Care Med 1997;155:1267-1272.
6. Ulrik CS, Backer V. Nonreversible airflow obstruction in life-long non-smokers with moderate to severe asthma. Eur Respir J 1999;14:892-896. (Pubitemid 29519354)
7. Burrows B. Airways obstructive diseases: pathogenetic mechanisms and natural histories of the disorders. Med Clin North Am 1990;74:547-559.
8. Phelan PD, Robertson CF, Olinsky A. The Melbourne asthma study: 1964-1999. J Allergy Clin Immunol 2002;109:189-194. (Pubitemid 34158282)
9. Stern DA, Morgan WJ, Wright AL, Guerra S, Martinez FD. Poor airway function in early infancy and lung function by age 22 years: a nonselective longitudinal cohort study. Lancet 2007;370:758-764. (Pubitemid 47320800)
10. Sears MR, Greene JM, Willan AR, Wiecek EM, Taylor DR, Flannery EM, Cowan JO, Herbison GP, Silva PA, Poulton R. A longitudinal population-based, cohort study of childhood asthma followed to adulthood. N Engl J Med 2003;349:1414-1422. (Pubitemid 37211056)
11. Perret JL, Dharmage SC, Matheson MC, Johns DP, Gurrin LC, Burgess JA, Marrone J, Markos J, Morrison S, Feather I, et al. The interplay between lifetime asthma, smoking, and atopy on fixed airflow obstruction in middle age. Am J Respir Crit Care Med 2013;187:42-48.
12. Reed CE. The natural history of asthma. J Allergy Clin Immunol 2006;118:543-548. (Pubitemid 44301404)
13. Burrows B, Bloom JW, Traver G, Cline M. The course and prognosis of different forms of chronic airways obstruction in a sample from general population. N Engl J Med 1987;317:1309-1314. (Pubitemid 17153012)
14. Haldar P, Pavord ID, Shaw DE, Berry MA, Thomas M, Brightling CE, Wardlaw AJ, Green RH. Cluster analysis and clinical asthma phenotypes. Am J Respir Crit Care Med 2008;178:218-224.
15. Lee JH, Haselkorn T, Borish L, Rasouliyan L, Chipps BE, Wenzel SE. Risk factors associated with persistent airflow limitation in severe or difficult-to-treat asthma. Chest 2007;132:1882-1889.